Seroprevalence of Hepatitis B Virus among Adults at High Risk for HIV Transmission Two Decades after Implementation of Nationwide Hepatitis B Virus Vaccination Program in Taiwan

被引:22
作者
Sun, Hsin-Yun [1 ,2 ]
Cheng, Chien-Yu [3 ]
Lee, Nan-Yao [4 ,5 ]
Yang, Chia-Jui [6 ]
Liang, Shiou-Haur [7 ]
Tsai, Mao-Song [6 ]
Ko, Wen-Chien [4 ,5 ]
Liu, Wen-Chun [1 ,2 ]
Wu, Pei-Ying [8 ]
Wu, Cheng-Hsin [1 ,2 ]
Lin, Hsi-Hsun [7 ]
Hung, Chien-Ching [1 ,2 ,9 ,10 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
[3] Tao Yuan Gen Hosp, Minist Hlth & Welf, Dept Internal Med, Tao Yuan, Taiwan
[4] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan
[5] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan
[6] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan
[7] I Shou Univ, Dept Med, E Da Hosp, Kaohsiung, Taiwan
[8] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan
[9] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[10] China Med Univ, Taichung, Taiwan
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNIZATION PROGRAM; UNITED-STATES; HEPATOCELLULAR-CARCINOMA; C VIRUS; INFECTION; CHILDREN; RECOMMENDATIONS; ANTIBODY; IMMUNITY;
D O I
10.1371/journal.pone.0090194
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Seroprevalence of hepatitis B virus (HBV) after implementation of universal neonatal HBV vaccination and catch-up vaccination programs remains rarely investigated among the adults who were born in the vaccination era (in or after 1986) and engaged in high-risk sexual behaviors. Materials and Methods: Between 2006 and 2012, we determined HBV surface antigen ([HBsAg), anti-HBs, and HBV core antibody (anti-HBc), hepatitis C virus antibody (anti-HCV) and rapid plasma reagin titers among HIV-infected men who have sex with men (MSM) born during 1984-1985 (Group I: 244 persons) and those born in or after 1986 (Group II: 523), and HIV-uninfected MSM (Group III: 377) and heterosexuals (Group IV: 217) born in or after 1986. Prevalence and incidence of HBV infection were estimated and multivariate analysis was performed to identify factors associated with HBsAg positivity. Results: Compared with Group I, Groups II-IV had a significantly lower prevalence of HBsAg positivity (7.8% vs 3.7%, 2.4%, and 3.2%, respectively); and the prevalence of anti-HBc positivity was also lower for Groups III and IV (30.3% vs. 19.6%, and 18.0%, respectively), but no difference was observed between Groups I and II (30.3% vs. 26.3%). In multivariate analysis, HBsAg positivity was significantly associated with syphilis (adjusted odds ratio, 2.990; 95% confidence interval, 1.502-5.953) and anti-HCV positivity (adjusted odds ratio, 3.402; 95% confidence interval, 1.091-10.614). In subjects of Group II with all-negative HBV markers at baseline, the incidence rate of HBsAg seroconversion was 0.486 episodes per 100 person-years; and for those who received combination antiretroviral therapy containing lamivudine and/or tenofovir, none developed HBsAg seroconversion during the follow-up. Conclusions: Among the adults who were born in or after 1986 and engaged in high-risk sexual behaviors in Taiwan, neonatal HBV vaccination and catch-up vaccination programs conferred long-term protection against HBsAg seroconversion and HBsAg positivity was associated with syphilis and anti-HCV positivity.
引用
收藏
页数:8
相关论文
共 35 条
[1]  
Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6
[2]   Hepatitis B virus infection [J].
Chang, Mei-Hwei .
SEMINARS IN FETAL & NEONATAL MEDICINE, 2007, 12 (03) :160-167
[3]   Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children [J].
Chang, MH ;
Chen, CJ ;
Lai, MS ;
Hsu, HM ;
Wu, TC ;
Kong, MS ;
Liang, DC ;
Shau, WY ;
Chen, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) :1855-1859
[4]   Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants [J].
Chen, Chien-Hung ;
Yang, Pei-Ming ;
Huang, Guan-Tarn ;
Lee, Hsuan-Shu ;
Sung, Juei-Low ;
Sheu, Jin-Chuan .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2007, 106 (02) :148-155
[5]  
CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597
[6]   Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan [J].
Chiang, Chun-Ju ;
Yang, Ya-Wen ;
You, San-Lin ;
Lai, Mei-Shu ;
Chen, Chien-Jen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (09) :974-976
[7]   ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND SUBOPTIMAL RESPONSE TO HEPATITIS-B VACCINATION [J].
COLLIER, AC ;
COREY, L ;
MURPHY, VL ;
HANDSFIELD, HH .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (02) :101-105
[8]   Influence of prior HIV-1 infection on the development of chronic hepatitis B infection [J].
Gatanaga, H ;
Yasuoka, A ;
Kikuchi, Y ;
Tachikawa, N ;
Oka, S .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (03) :237-239
[9]   Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus Infection [J].
Gatanaga, Hiroyuki ;
Hayashida, Tsunefusa ;
Tanuma, Junko ;
Oka, Shinichi .
CLINICAL INFECTIOUS DISEASES, 2013, 56 (12) :1812-1819
[10]   CLINICAL ASPECTS OF THE INTERACTIONS BETWEEN HUMAN-IMMUNODEFICIENCY-VIRUS AND THE HEPATOTROPIC VIRUSES [J].
HORVATH, J ;
RAFFANTI, SP .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (03) :339-347